Truqap 200 MG tablet 64S
Ended Awarded Last action
- Contract number
- SPE2DR26F57KF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,158
Award facts
- Contract value 100% obligated
- $33,158.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $33,158.48 to AmerisourceBergen Drug Corp for 64 tablets of Truqap 200 mg, a pharmaceutical product supporting military healthcare operations. This contract, awarded on January 15, 2026, with completion targeted for February 6, 2026, utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award through open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office operations. AmerisourceBergen Drug Corp operates as a child entity under Cencora, Inc., which rebranded from AmerisourceBergen and serves as the parent organization in the pharmaceutical supply chain.
This delivery order is issued under a significantly larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical, valued at up to $999,999,999.00 through December 2026. That prime vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The parent company, Cencora, Inc., holds an additional substantial IDC with the Defense Logistics Agency valued at up to $999,999,999.00 through December 31, 2031, demonstrating the organization's critical role in fulfilling federal pharmaceutical procurement requirements for military treatment facilities, veterans' healthcare programs, and other federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26F57KF?
SPE2DR26F57KF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26F57KF worth?
The government has obligated $33,158 on SPE2DR26F57KF.
Is contract SPE2DR26F57KF an order under another contract?
Yes. SPE2DR26F57KF is a delivery order under SPE2DR25D2006, an indefinite delivery contract.
Was contract SPE2DR26F57KF competed?
The extent of competition for SPE2DR26F57KF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award